ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)

SHE:300254 Revenue

ShanXi C&Y Pharmaceutical Group Co.,LTD. had revenue of 173.80M CNY in the quarter ending March 31, 2026, a decrease of -4.37%. This brings the company's revenue in the last twelve months to 862.85M, up 2.86% year-over-year. In the year 2025, ShanXi C&Y Pharmaceutical Group Co.,LTD. had annual revenue of 870.79M with 2.86% growth.

• Revenue (ttm): 862.85M
• Revenue Growth: +2.86%
• P/S Ratio: 2.85
• Revenue / Employee: 742.56K
• Employees: 1,196
• Market Cap: 2.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	870.79M	24.18M	2.86%
Dec 31, 2024	846.61M	47.30M	5.92%
Dec 31, 2023	799.31M	-29.69M	-3.58%
Jan 1, 2023	829.00M	-101.38M	-10.90%
Jan 1, 2022	930.37M	82.30M	9.70%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error